搜索临床试验以:西曲伐替尼和替雷利珠单抗
总计272240个结果
-
BeiGene完全的
-
Grupo Español Multidisciplinar de MelanomaMirati Therapeutics Inc.; BeiGene主动,不招人
-
Peking University Cancer Hospital & Institute招聘中
-
HutchmedBeiGene主动,不招人
-
National Taiwan University HospitalNational Taiwan University Hospital, Yun-Lin Branch招聘中
-
Anhui Provincial HospitalHenan Cancer Hospital; First Affiliated Hospital Xi'an Jiaotong University; First Affiliated Hospital...招聘中
-
Shanghai Zhongshan HospitalTakeda; BeiGene尚未招聘NK/T 细胞淋巴瘤编号
-
Seoul National University HospitalBeiGene主动,不招人
-
Tianjin Medical University Second Hospital招聘中
-
Beijing Friendship HospitalPeking University First Hospital; Peking University People's Hospital; Peking Union Medical College... 和其他合作者招聘中
-
Australia New Zealand Gynaecological Oncology GroupBeiGene撤销
-
Sarah GoldbergMirati Therapeutics Inc.终止肺部疾病 | 癌,非小细胞肺癌 | 肺肿瘤 | 转移性肺非小细胞癌 | PD-L1基因突变 | 派姆单抗 | IV 期肺癌非小细胞癌 AJCC v7 | 高级治疗-天真的 PD-L1 | 西曲伐替尼美国
-
USDA Grand Forks Human Nutrition Research CenterCalifornia Polytechnic State University-San Luis Obispo完全的
-
Sykehuset Asker og BaerumUllevaal University Hospital完全的
-
Peking University Cancer Hospital & Institute招聘中
-
University of British ColumbiaSocial Sciences and Humanities Research Council of Canada完全的
-
Jiangsu Yahong Meditech Co., Ltd aka Asieris招聘中
-
Fudan University主动,不招人